MedTrace Logo

Galectin and Respiratory Weaning

NCT05054556 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2023-09-26

No results posted yet for this study

Summary

Galectin-3 is a biomarker for fibrotic activity. In the course of invasive ventilation, fibrotic changes in the lungs may occur. The study aims to investigate whether the level of galectin-3 levels correlates with clinical weaning parameters.

Conditions

  • Galectin-3 During Respiratory Weaning

Interventions

DIAGNOSTIC_TEST

Labaratory tests

Estimation of serum levels of the following parameters: galectin-3, proBNP, TNI, proGRP, CA15-3, CK, creatinine, urea, crp, pct, leucozytes

Sponsors & Collaborators

  • Asklepios Schlossberg Clinic Bad Koenig

    collaborator UNKNOWN

  • Asklepios Neurological Clinic Bad Salzhausen

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-11-01
Primary Completion
2024-12-31
Completion
2025-06-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05054556 on ClinicalTrials.gov